GlaxoSmithKline Oncology is committed to working in partnership with academia to develop and support expertise in oncology in the UK.
As part of that commitment GSK is offering a four-year UK-based CASE (Collaborative Award in Science and Engineering) PhD Scholarship in the field of oncology/haematology.
The aim of the GSK Oncology CASE PhD scholarship is to provide an opportunity for academic collaboration and a first class training experience in an industrial environment within the setting of GSK Oncology R&D.
Dr Melania Capasso, Centre for Cancer & Inflammation, Barts Cancer Institute, Queen Mary University of London
GSK would like to thank all applicants for their submissions. GSK will be supporting a further oncology scholarship next year - look out for details.
The applications for the scholarship award, created to support cutting-edge oncology research in the UK, were reviewed by GSK R&D in the first instance and subsequently evaluated by an independent panel of eminent UK oncology and haematology experts. The five finalists presented their proposals to the judging panel on 30 November 2011 where the successful candidate was selected.
The panel comprised of the following leading cancer researchers and clinicians;
Professor Alan Ashworth speaking of the award said: "Joint industry-academic research efforts are vital in the quest for furthering scientific progress – especially in the current climate. With this award, GSK have created an exciting opportunity to support and showcase cutting-edge UK research and it was fascinating to be involved in the judging process. All the finalist proposals were outstanding in their potential to further scientific progress in cancer research so choosing the final winner was a difficult decision."
For any enquiries please contact phd.scholarship@gsk.com.